Hillhouse, others set to invest $630 million in China’s Giant Biogene -sources
BEIJING/HONG KONG (Reuters) – China’s Xian Giant Biogene Technology has embarked on a fundraising round that will likely see Hillhouse Capital Group and others buy at least 4 billion yuan ($630 million) worth of shares, two people familiar with the matter said. The share sale, a combination of new and existing shares, will value the …
Hillhouse, others set to invest $630 million in China’s Giant Biogene -sources Read More »